The clock is ticking, or more precisely, calendar pages are turning for businesses that made OTC hand sanitizers available in the US during the COVID-19 pandemic to notify the Food and Drug Administration if they no longer provide the products.
The FDA on 16 July announced it is reminding companies which registered with the agency solely to manufacture hand sanitizers during the COVID-19 public health emergency that they will be subject to fiscal year 2025 OTC monograph user fees if they
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?